🥩

PKD for Chronic Disease Treatment

Oct 3, 2025

Overview

Dr. Anthony Chafee interviews Dr. Zsófia Clemens of Paleo Medicina Hungary to discuss the use of a strict animal-based, high-fat ketogenic diet (PKD) in treating chronic diseases, including cancer, epilepsy, and autoimmune disorders. The discussion covers clinical outcomes, challenges in mainstream acceptance, and barriers to publishing positive case studies.

Introduction to PKD and Paleo Medicina

  • Paleo Medicina Hungary is a medical and research group using the PKD, a strict animal-based, high-fat ketogenic diet.
  • PKD focuses on meat and fat from large mammals, following ancestral dietary patterns, and aims to maintain ketosis.
  • Dr. Clemens asserts that there is one optimal therapeutic diet for all humans, regardless of demographics.

Rationale and Clinical Application

  • Chronic Western diseases are viewed as consequences of inappropriate diets rather than true diseases.
  • PKD is applied to a wide range of conditions: cancers, epilepsy, diabetes, autoimmune and neurodegenerative diseases.
  • The protocol is standardized (meat + animal fat, roughly a 100g:35g meat-to-fat ratio to ensure ketosis).

Outcomes in Cancer and Chronic Disease

  • PKD has stabilized or put into remission some aggressive cancers, like glioblastoma (GBM), with several years progression-free survival recorded.
  • Colorectal cancer cases have shown full tumor disappearance and resolution of metastases on PKD.
  • Other chronic diseases (Crohn’s, ulcerative colitis, rheumatoid arthritis) have demonstrated reversibility or significant symptom improvement.

Epilepsy and Neurological Disorders

  • A century of data supports ketogenic diets in epilepsy, particularly in children.
  • Approximately 50% of epilepsy patients become seizure-free on a well-formulated ketogenic diet, outperforming pharmacological therapy.
  • PKD has shown benefits in multiple sclerosis, Parkinson’s, and Alzheimer’s, with improvements varying by disease and patient adherence.

Barriers to Mainstream Adoption

  • Mainstream medicine favors pharmacological treatments over dietary interventions due to convenience and systemic inertia.
  • Strict dietary protocols are time-intensive for practitioners and require high patient compliance.
  • Publishing positive outcomes of dietary therapies (especially full recoveries) is difficult due to editorial and systemic biases.

Professional and Personal Experience

  • Both Dr. Clemens and her colleagues follow the PKD for credibility and practical expertise.
  • Many practitioners are becoming less hostile to low-carb approaches, though systemic change is slow.
  • Family adoption of PKD is rare, even among practitioners.

Challenges in Research and Publication

  • Publishing case reports of disease reversal with PKD is often rejected due to entrenched beliefs about disease incurability.
  • Animal studies showing similar reversals are accepted, but human data faces more resistance.
  • Alternative methods of sharing results (social media, direct patient education) are increasingly important.

Decisions

  • Promote PKD as a standardized therapeutic diet for chronic disease management.
  • Continue patient-centered education and outreach due to barriers in mainstream publications.

Action Items

  • TBD – Dr. Clemens: Continue seeking alternative publishing avenues for PKD case studies.
  • TBD – Dr. Chafee: Share supporting studies and resources with colleagues and patients as clinical situations arise.
  • TBD – Both: Encourage patient and public advocacy to drive clinical and systemic change.

Recommendations / Advice

  • Patients with chronic or refractory conditions should consider medically-supervised PKD as a treatment option.
  • Physicians should familiarize themselves with emerging evidence on dietary therapy and remain neutral/supportive toward patient choices.
  • Patients should demand informed consent and be presented with evidence-based dietary options alongside conventional care.

Questions / Follow-Ups

  • How can data on full recoveries with PKD be more widely disseminated?
  • What strategies can increase mainstream medical acceptance of dietary interventions?
  • How can patient compliance and support be improved for strict dietary protocols?